Kinetics of the cell cycle arrest biomarkers (timp2 and igfbp7) for the diagnosis of acute kidney injury in critically ill covid-19 patients

HIGHLIGHTS

• who: Massimiliano Greco and collaborators from the Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini, Pieve Emanuele, Milan, Italy have published the research: Kinetics of the Cell Cycle Arrest Biomarkers (TIMP2 and IGFBP7) for the Diagnosis of Acute Kidney Injury in Critically Ill COVID-19 Patients, in the Journal: Diagnostics 2023, 317 of 30/03/2020
• what: The aim of this study was to assess the utility of_[TIMP2]*[IGFBP7] biomarkers as predictors of severe AKI in a population of critically ill COVID-19 patients.
• how: The authors conducted an observational . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.